Menopausal Symptoms

Hormonal Treatments for Breast Cancer: Do They Cause Depression?

Aromatase inhibitors (AIs) are the preferred hormonal therapy for postmenopausal women with estrogen sensitive breast cancer.  While the selective estrogen receptor modulators (SERMs), such as tamoxifen and raloxifene, are used in premenopausal women with estrogen sensitive breast cancer, the aromatase inhibitors (e.g., anastrozole, letrozole, and exemestane) have been shown to be more effective and safer than the SERMs in postmenopausal women. 

By |2015-08-06T11:57:42-04:00April 9th, 2013|Breast Cancer, Depressive Disorders, Hormone Therapy, Menopausal Symptoms|Comments Off on Hormonal Treatments for Breast Cancer: Do They Cause Depression?

Hypnotherapy for Hot Flashes

Peri- and post-menopausal women have various options for the management of hot flashes, including hormone replacement therapy, SSRIs, and gabapentin. It looks as if hypnosis may also be helpful.  In a recent study, researchers randomly assigned postmenopausal women to hypnotherapy or "structured attention," which was used as a control intervention.

By |2015-08-11T09:39:06-04:00October 28th, 2012|Alternative & Complementary, Menopausal Symptoms, Treatment, Vasomotor Symptoms|Comments Off on Hypnotherapy for Hot Flashes

Extended Release Gabapentin (Neurontin) for Hot Flashes

Multiple studies have shown that gabapentin (Neurontin) at 600-2400 mg/day in divided doses is effective for treating hot flashes in menopausal women. This study examines the efficacy of an extended release preparation.

By |2025-12-21T08:42:13-04:00October 21st, 2012|Medication, Menopausal Symptoms, Treatment, Vasomotor Symptoms|Comments Off on Extended Release Gabapentin (Neurontin) for Hot Flashes

Low Dose Paroxetine for the Treatment of Hot Flashes

For decades, estrogen has been used to treat menopausal symptoms, including night sweats and hot flashes.  However, after studies reported that estrogen increases the risk of cardiovascular disease and breast cancer, many patients and clinicians have looked into alternative treatments for hot flashes, including selective serotonin reuptake inhibitors (SSRIs).

By |2015-08-12T10:51:17-04:00October 16th, 2012|Medication, Menopausal Symptoms, Treatment, Vasomotor Symptoms|Comments Off on Low Dose Paroxetine for the Treatment of Hot Flashes

New Research from the CWMH: Escitalopram and Sleep in Midlife Women with Vasomotor Symptoms

Selective serotonin and serotonin-norepinephrine inhibitors (SSRIs and SNRIs) have been shown to be effective for the treatment of hot flashes.  However, these agents may carry certain side effects, including sexual side effects and sleep disturbance.  These two side effects may be particularly concerning to peri- and postmenopausal women who, in addition to having vasomotor symptoms, are more likely to experience sexual dysfunction and sleep disruption than premenopausal women.

By |2018-06-08T09:03:31-04:00August 20th, 2012|Medication, Menopausal Symptoms, Research at CWMH, Sleep Disorders, Treatment|Comments Off on New Research from the CWMH: Escitalopram and Sleep in Midlife Women with Vasomotor Symptoms

Weight Loss and a Low-Fat Diet Help to Reduce Hot Flashes in Menopausal Women

Various studies have shown that women with a higher body mass index (BMI) or a higher percent of body fat have more frequent or more severe menopausal symptoms.  In a recent study, researchers evaluated the impact of a low-fat diet on vasomotor symptoms in a group of 17,473 postmenopausal women between the ages of 50 and 79.

By |2015-08-12T12:19:50-04:00August 8th, 2012|Alternative & Complementary, Menopausal Symptoms, Prevention, Vasomotor Symptoms|Comments Off on Weight Loss and a Low-Fat Diet Help to Reduce Hot Flashes in Menopausal Women

New Research from the CWMH: Surgically Induced Menopause No Worse than Natural in Terms of Risk for Depression, Anxiety

Each year about 600,000 women in the United States undergo a hysterectomy.  Somewhere between 55% and 80% of these women who also have their ovaries removed along with the uterus—a procedure known as oophorectomy.  After the removal of the ovaries, menopause follows immediately and is associated with a constellation of symptoms including hot flashes and insomnia, as well as depression and anxiety. 

By |2016-03-28T13:02:53-04:00August 2nd, 2012|Depressive Disorders, Menopausal Symptoms, Prevalence & Risk Factors, Research at CWMH|Comments Off on New Research from the CWMH: Surgically Induced Menopause No Worse than Natural in Terms of Risk for Depression, Anxiety

New Research from the CWMH: History of Depression and Anxiety Predict Lower Quality of Life in Midlife Women

The National Comorbidity Survey estimates that by the time women reach midlife, approximately 23% have experienced at least one episode of major depression and 30% have been diagnosed with an anxiety disorder.  Depression and anxiety disorders are each associated with impaired functioning and lower quality of life (QOL).  There is also some data to suggest that, even after a depressive episode resolves, those with a history of a affective illness have a lower quality of life than those without histories of depression, with impairment in social and interpersonal functioning.

By |2016-03-28T13:02:53-04:00July 24th, 2012|Anxiety Disorders, Depressive Disorders, Menopausal Symptoms, Research at CWMH|Comments Off on New Research from the CWMH: History of Depression and Anxiety Predict Lower Quality of Life in Midlife Women

Soy Supplements: No Effect on Cognition in Postmenopausal Women

Soy-based products have long been touted as a treatment for menopausal symptoms.  However, many of the clinical studies measuring the effectiveness of dietary sources of soy isoflavones (e.g., soy beverages, soy powder) for the treatment of menopausal vasomotor symptoms (i.e., hot flushes, night sweats) have been negative.  Less is known about the effects of soy on cognition.  A large clinical trial suggests that soy may not have any positive effects on cognition in postmenopausal women.

By |2015-08-12T12:31:30-04:00July 18th, 2012|Alternative & Complementary, Cognition, Menopausal Symptoms, Treatment|Comments Off on Soy Supplements: No Effect on Cognition in Postmenopausal Women
Go to Top